CervoMed to Participate in the Emerging Growth Conference

Rhea-AI Summary

CervoMed Inc. (NASDAQ: CRVO), a clinical stage company specializing in treatments for age-related neurologic disorders, has announced its participation in the upcoming Emerging Growth Conference. The company's management will deliver a virtual corporate presentation on Thursday, July 18, 2024, at 1:10 PM ET.

Investors and interested parties can access the webcast of the presentation through the provided link or via the Investor section of CervoMed's official website. This event offers an opportunity for stakeholders to gain insights into CervoMed's current projects, future plans, and potential growth prospects in the field of neurologic disorder treatments.

BOSTON, July 17, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company’s Management will present virtually at the Emerging Growth Conference.

Presentation Details
Format: Corporate presentation
Date: Thursday, July 18, 2024
Time: 1:10 PM ET
Webcast Link: click here

The webcast of the presentation will be accessible in the Investor section of the CervoMed website https://www.cervomed.com/.

About CervoMed
CervoMed Inc. (the “Company”) is a clinical-stage company focused on developing treatments for age-related neurologic disorders. The Company is currently developing neflamapimod, an investigational, orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that causes disease in DLB and certain other major neurological disorders. Neflamapimod is currently being evaluated in a Phase 2b study in patients with DLB.

Investor Contact:
PJ Kelleher
LifeSci Advisors
Investors@cervomed.com
617-430-7579

FAQ

When is CervoMed (CRVO) presenting at the Emerging Growth Conference?

CervoMed (CRVO) is presenting at the Emerging Growth Conference on Thursday, July 18, 2024, at 1:10 PM ET.

How can I watch CervoMed's (CRVO) presentation at the Emerging Growth Conference?

You can watch CervoMed's (CRVO) presentation via the webcast link provided in the press release or through the Investor section of CervoMed's website at https://www.cervomed.com/.

What is the focus of CervoMed (CRVO) as a company?

CervoMed (CRVO) is a clinical stage company focused on developing treatments for age-related neurologic disorders.

What type of presentation will CervoMed (CRVO) give at the Emerging Growth Conference?

CervoMed (CRVO) will deliver a virtual corporate presentation at the Emerging Growth Conference.